[Ischaemic heart disease].
In the year 2011, cardiovascular diseases were responsible of 31.2% of total deaths in Spain. The absolute number of cases of acute coronary syndrome in this year will be approximately 115,752 cases (95%CI: 114,822-116,687). The prevalence of stable angina in the population aged 25-74 years is 2.6% in men and 3.5% in women. Cardiovascular diseases were in the year 2011 the first cause of hospitalizations representing 14.1% of the total hospitalizations. Diagnose of ischaemic heart disease and acute myocardial infarction were responsible of 110,950 and 50,064 hospitalizations, respectively. In the year 2003, the hospitalization rate was 314 while in the year 2011 was 237 per 100,000, a reduction of 24.4%. The average cost of hospitalization due to ischaemic heart disease in 1997 was 3,093.7euros while in the year 2011 was 7,028.71euros. Cardiovascular mortality rates have decreased from 2007 to 2011, showing a relative reduction of 7% in women and 8% in men. With regard to myocardial infarction, it was observed a relative reduction of 17% in men and 20% in women. According to EUROASPIREIII survey done in 8,966 patients with ischaemic heart disease in Europe, 17% of patients were still smokers, 35% were obese, 56% has uncontrolled blood pressure, 51% has raised blood cholesterol and 25% were diabetics. With regard to drugs utilisation, 91% were treated with antiplatelets agents, 80% with beta blockers, 71% with ACE inhibitors/ARBs.
Unidad de Investigación, Equip d'Atenció Primària Sardenya, Unidad Docente ACEBA, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España. Electronic address: cbrotons@eapsardenya.cat.
Carlos
C
Brotons
Consulta de Riesgo Cardiovascular, Servicio de Medicina Interna, Complejo Asistencial de Palencia, Palencia, España.
José I
JI
Cuende
Unidad de Hipertensión y Lípidos, Hospital General Universitario Reina Sofía, Murcia, España.
Jacinto
J
Fernández Pardo
Unitat de Investigació Clínica (UIC), Unitat de Medicina Vascular i Metabolisme, Hospital Universitari Sant Joan, Reus, Tarragona, España.
Nuria
N
Plana
Unidad de Investigación, Equip d'Atenció Primària Sardenya, Unidad Docente ACEBA, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España.
Irene
I
Moral
D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D005260:Female; D006760:Hospitalization / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors
Cardiopatía isquémica; Ichemic heart disease; Morbidity; Morbilidad; Mortalidad; Mortality; Prevención secundaria; Secondary prevention